The company announced that VIZZ (aceclidine ophthalmic solution) 1.44% received FDA approval as the first and only aceclidine-based eye drop for treating blurry near vision. Lenz plans to make samples ...

Agios Pharmaceuticals gears up for a pivotal 2025 with key PYRUKYND milestones, including FDA decisions for thalassemia.

Sanofi's SAR446523 gains FDA orphan drug status, offering hope for relapsed multiple myeloma patients with its targeted ...

Artificial Intelligence (AI) continues to revolutionize industries and is poised to bring transformative change in healthcare delivery, ...

In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected ...

Eli Lilly's diabetes drug Mounjaro demonstrated superior efficacy to its predecessor Trulicity in reducing heart attack and ...

Congress and the FDA are pushing pharmaceutical companies to replace animals with technology for drug research. That’s a long ...

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...

A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized ...